Use of in vivo nasal transepithelial potential difference to evaluate efficacy in CF gene therapy phase I trials.
Chinet
T C
TC
D017321:Clinical Trials, Phase I as Topic; D003550:Cystic Fibrosis / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D004553:Electric Conductivity; D015316:Genetic Therapy; D006801:Humans; D017136:Ion Transport / Q000502:physiology; D009297:Nasal Mucosa / Q000502:physiology; D012680:Sensitivity and Specificity